Evaluation and management of deficiency of adenosine deaminase 2 : : an international consensus statement
Abstract: Importance Deficiency of adenosine deaminase 2 (DADA2) is a recessively inherited disease characterized by systemic vasculitis, early-onset stroke, bone marrow failure, and/or immunodeficiency affecting both children and adults. DADA2 is among the more common monogenic autoinflammatory diseases, with an estimate of more than 35 000 cases worldwide, but currently, there are no guidelines for diagnostic evaluation or management.
Objective To review the available evidence and develop multidisciplinary consensus statements for the evaluation and management of DADA2.
Evidence Review The DADA2 Consensus Committee developed research questions based on data collected from the International Meetings on DADA2 organized by the DADA2 Foundation in 2016, 2018, and 2020. A comprehensive literature review was performed for articles published prior to 2022. Thirty-two consensus statements were generated using a modified Delphi process, and evidence was graded using the Oxford Center for Evidence-Based Medicine Levels of Evidence.
Findings The DADA2 Consensus Committee, comprising 3 patient representatives and 35 international experts from 18 countries, developed consensus statements for (1) diagnostic testing, (2) screening, (3) clinical and laboratory evaluation, and (4) management of DADA2 based on disease phenotype. Additional consensus statements related to the evaluation and treatment of individuals with DADA2 who are presymptomatic and carriers were generated. Areas with insufficient evidence were identified, and questions for future research were outlined.
Conclusions and Relevance DADA2 is a potentially fatal disease that requires early diagnosis and treatment. By summarizing key evidence and expert opinions, these consensus statements provide a framework to facilitate diagnostic evaluation and management of DADA2
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
JAMA network open. - 6, 5 (2023) , e2315894, ISSN: 2574-3805
- Ereignis
-
Veröffentlichung
- (wo)
-
Freiburg
- (wer)
-
Universität
- (wann)
-
2023
- Urheber
- DOI
-
10.1001/jamanetworkopen.2023.15894
- URN
-
urn:nbn:de:bsz:25-freidok-2370933
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:57 MEZ
Datenpartner
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lee, Pui Y
- Grimbacher, Bodo
- Ombrello, Amanda K.
- Universität
Entstanden
- 2023
Ähnliche Objekte (12)
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
Klinische Erforschung der CTLA-4-Insuffizienz
STAT1-Mutationen in einer Kohorte von 62 Patienten mit chronischer mukokutaner Kandidose
Inborn errors of immunity associated with defects of self‐tolerance checkpoints: the CD28 family
Immunological phenotype of LRBA-deficient mice
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome
Observation and long-term follow-up of patients with isolated hypogammaglobulinaemia at the Royal Free Hospital, London
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
Klinische Erforschung der CTLA-4-Insuffizienz
STAT1-Mutationen in einer Kohorte von 62 Patienten mit chronischer mukokutaner Kandidose
Inborn errors of immunity associated with defects of self‐tolerance checkpoints: the CD28 family
Immunological phenotype of LRBA-deficient mice
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome
Observation and long-term follow-up of patients with isolated hypogammaglobulinaemia at the Royal Free Hospital, London
Identifikation des genetischen Defekts in einer iranischen Familie mit chronischer mucocutaner Candidose
Long-term outcome of LRBA deficiency in 76 patients after various treatment modalities as evaluated by the immune deficiency and dysregulation activity (IDDA) score
Deleterious mutations in LRBA are associated with a syndrome of immune deficiency and autoimmunity
Klinische Erforschung der CTLA-4-Insuffizienz
STAT1-Mutationen in einer Kohorte von 62 Patienten mit chronischer mukokutaner Kandidose
Inborn errors of immunity associated with defects of self‐tolerance checkpoints: the CD28 family
Immunological phenotype of LRBA-deficient mice
Human CARMIL2 deficiency underlies a broader immunological and clinical phenotype than CD28 deficiency
Rapid flow cytometry-based test for the diagnosis of lipopolysaccharide responsive beige-like anchor (LRBA) deficiency
14 years after discovery : : clinical follow-up on 15 patients with Inducible CO-Stimulatior deficiency
Dominant-negative mutations in human IL6ST underlie hyper-IgE syndrome